搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
pharmaphorum
7 小时
Sanofi's tolebrutinib cuts MS progression by 31% in trial
Data from the HERCULES trial presented at the ECTRIMS conference in Copenhagen, Denmark, today showed that tolebrutinib was ...
pharmaphorum
8 小时
J&J nets another key approval for blockbuster hope Rybrevant
J&J's high expectations for Rybrevant are driven mainly by its August approval with Lazcluze, which outperformed Tagrisso in ...
pharmaphorum
8 小时
5 patient travel strategies to impact enrolment diversity in clinical research
The challenge persists, but, with a renewed focus from regulatory bodies and trial sponsors alike on improving enrolment ...
pharmaphorum
10 小时
Job losses loom at Achilles as TIL therapy platform is cut
Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping ...
pharmaphorum
11 小时
Astellas brings its first digital health product to US
Astellas is ready to launch its first digital health offering in the US, a toolkit dedicated to providing at-home monitoring ...
pharmaphorum
1 天
Vanda slams FDA rejection of gastroparesis drug
The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious ...
pharmaphorum
1 天
Supply chain resilience in pharma: Delivering consistency amidst global events
Global events can pose significant challenges to the supply of APIs, and thus the continuity of drug supply. Any disruption ...
pharmaphorum
1 天
Neuralink gets breakthrough tag for sight-restoring implant
Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that ...
pharmaphorum
1 天
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
The Centers for Medicare & Medicaid Services (CMS) has said it will announce the next 15 drugs in scope for the second round ...
pharmaphorum
1 天
Daiichi Sankyo's Vanflyta gets NICE nod for leukaemia
NICE has recommended Vanflyta (quizartinib) for routine NHS commissioning as an induction, consolidation, and maintenance ...
pharmaphorum
1 天
Organon makes dermatology play with $1.2bn Dermavant buyout
Organon is paying $175 million upfront to buy Roivant's dermatology unit Dermavant and its topical psoriasis therapy Vtama, ...
pharmaphorum
1 天
Respiratory biotech Upstream joins Nasdaq IPO surge
Upstream Bio has become the latest biotech to chance its arm with a public listing in the US, hoping to raise funds for ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈